Porcilis PCV ID

RSS

Porcine circovirus vaccine (inactivated)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Porcilis PCV ID. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Porcilis PCV ID.

For practical information about using Porcilis PCV ID, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 04/04/2022

Authorisation details

Product details
Name
Porcilis PCV ID
Agency product number
EMEA/V/C/003942
Active substance
porcine circovirus type 2 ORF2 subunit antigen
International non-proprietary name (INN) or common name
Porcine circovirus vaccine (inactivated)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AA07
Publication details
Marketing-authorisation holder
Intervet International B.V.
Revision
3
Date of issue of marketing authorisation valid throughout the European Union
28/08/2015
Contact address

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

09/09/2021 Porcilis PCV ID - EMEA/V/C/003942 - II/0005/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Immunologicals for suidae

  • Inactivated viral vaccines

Therapeutic indication

For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by PCV2 infection. To reduce loss of daily weight gain and mortality associated with PCV2 infection.

Assessment history

How useful was this page?

Add your rating
Average
1 rating